ibandronic acid has been researched along with prednisolone in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Rexer, H | 1 |
Cellarius, C; Claassen, H; Glüer, CC; Kurz, B; Scholz-Ahrens, KE; Schrezenmeir, J; Schünke, M | 1 |
Griffith, JF; Hung, VY; Kwok, AW; Lee, KK; Lee, VW; Leung, PC; Li, EK; Li, M; Qin, L; Tam, LS; Wong, KC; Zhu, TY | 1 |
Eufémia Calmeiro, M; Gil, F; Gil, J; Mariano, P; Silva, S | 1 |
1 review(s) available for ibandronic acid and prednisolone
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for ibandronic acid and prednisolone
Article | Year |
---|---|
Ibandronate increases cortical bone density in patients with systemic lupus erythematosus on long-term glucocorticoid.
Topics: Absorptiometry, Photon; Adult; Bone Density; Bone Density Conservation Agents; Diphosphonates; Double-Blind Method; Female; Fractures, Bone; Glucocorticoids; Humans; Hydroxycholecalciferols; Ibandronic Acid; Lupus Erythematosus, Systemic; Middle Aged; Osteoporosis; Prednisolone; Tomography Scanners, X-Ray Computed | 2010 |
4 other study(ies) available for ibandronic acid and prednisolone
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
[Therapy of painful bone metastases in patients with prostate carcinoma. The AP 32/02 Study of the AUO].
Topics: Antineoplastic Agents; Bone Neoplasms; Diphosphonates; Humans; Ibandronic Acid; Male; Mitoxantrone; Pain; Patient Selection; Prednisolone; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Research Design; Treatment Outcome | 2004 |
Extracellular matrix changes in knee joint cartilage following bone-active drug treatment.
Topics: Alkaline Phosphatase; Animals; Bone Density Conservation Agents; Calcium; Cartilage, Articular; Chondrocytes; Diphosphonates; Estrogens; Extracellular Matrix; Female; Glycosaminoglycans; Ibandronic Acid; Ovariectomy; Prednisolone; Sodium Fluoride; Swine; Swine, Miniature; Vitamin D Deficiency | 2006 |
SAPHO syndrome: the value of classic drugs in the era of biologics.
Topics: Acquired Hyperostosis Syndrome; Anti-Inflammatory Agents; Bone and Bones; Bone Density Conservation Agents; Cyclosporine; Drug Therapy, Combination; Female; Humans; Ibandronic Acid; Immunosuppressive Agents; Middle Aged; Prednisolone; Radionuclide Imaging | 2020 |